Bone morphogenetic protein as an adjuvant in the treatment of kienbock's disease by vascular pedicle implantation

Journal of Hand Surgery: European Volume

Volumn 33, Issue 3, 2008, Pages 317-321

  Jones, Neil F ^a   Brown, E E ^a   Vogelin E ^a   Urist, M R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone morphogenetic protein; Kienbock's disease

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ADJUVANT THERAPY; ADULT; ARTICLE; AVASCULAR NECROSIS; BONE BLOOD FLOW; BONE MATRIX; CARPAL TUNNEL SYNDROME; CASE REPORT; CURETTAGE; EVIDENCE BASED MEDICINE; FEMALE; GRIP STRENGTH; HAND RADIOGRAPHY; HUMAN; KIENBOECK DISEASE; LUNATE BONE; METACARPAL BONE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; RANGE OF MOTION; STAGING; STEM CELL; TISSUE ENGINEERING; VASCULAR PEDICLE;

BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; LUNATE BONE; MIDDLE AGED; OSTEONECROSIS; SURGICAL FLAPS;

EID: 46249126369     PISSN: 17531934     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753193408090394     Document Type: Article

References (42)

1. Bilic, R, P Simic, and H Jelic (2006). Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. International Orthopedics, 30, 128-134.
2. Boden, SD, GL Martin, Jr, and MA Morone (1999). Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine, 24, 1179-1185.
3. Boden, SD, TA Zdeblick, HS Sandhu, and SE Heim (2000). The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine, 25, 376-381.
4. Bostrom, M, JM Lane, and E Tomin (1996). Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clinical Orthopaedics and Related Research, 327, 272-282.
5. Bouxsein, ML, TJ Turek, and CA Blake (2001). Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. Journal of Bone and Joint Surgery, 83A, 1219-1230.
6. Boyne, PJ, RE Marx, and M Nevins (1997). A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. International Journal of Periodontics and Restorative Dentistry, 17, 11-25.
7. Cook, SD, GC Baffes, and MW Wolfe (1994). The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. Journal of Bone and Joint Surgery, 76A, 827-838.
8. Cook, SD, RL Barrack, and A Shimmin (2001). The use of Osteogenic Protein-1 in reconstructive surgery of the hip. Journal of Arthroplasty, 16, 88-94.
9. Cook, SD, MW Wolfe, SL Salkeld, and DC Rueger (1995). Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. Journal of Bone and Joint Surgery, 77A, 734-750.
10. Friedlaender, GE, CR Perry, and JD Cole (2001). Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the treatment of tibial nonunions. Journal of Bone and Joint Surgery, 83A, S1-151-158.
11. Geesink, RG, NH Hoefnagels, and SK Bulstra (1999). Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. Journal of Bone and Joint Surgery, 81B, 710-718.
12. Govender, S, C Csimma, and HK Genant (2002). Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. Journal of Bone and Joint Surgery, 84A, 2123-2134.
13. Heckman, JD, W Ehler, and BP Brooks (1999). Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. Journal of Bone and Joint Surgery, 81A, 1717-1729.
14. Hori, Y, S Tamai, and H Okuda (1979). Blood vessel transplantation to bone. Journal of Hand Surgery, 4A, 23-33.
15. Itoh, T, M Mochizuki, and R Nishimura (1998). Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. Journal of Veterinary Medical Science, 60, 451-458.
16. Johnson, EE, and MR Urist (2000). Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clinical Orthopaedics and Related Research, 371, 61-74.
17. Johnson, EE, MR Urist, and GA Finerman (1988a). Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: A preliminary report. Clinical Orthopaedics and Related Research, 230, 257-265.
18. Johnson, EE, MR Urist, and GA Finerman (1988b). Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clinical Orthopaedics and Related Research, 236, 249-257.
19. Johnson, EE, MR Urist, and GA Finerman (1990). Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clinical Orthopaedics and Related Research, 250, 234-240.
20. Johnson, EE, MR Urist, and GA Finerman (1992). Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clinical Orthopaedics and Related Research, 277, 229-237.
21. Johnsson, R, B Stromqvist, and P Aspenberg (2002). Randomized radio-stereometric study comparing Osteogenic Protein-1 (BMP-7) and autograft bone in human, noninstrumented posterolateral lumbar fusion. Spine, 27, 2654-2661.
22. Jones, NF, EE Brown, and A Mostofi (2005). Healing of a scaphoid non-union using human Bone Morphogenetic Protein. Journal of Hand Surgery, 30A, 528-533.
23. Kujala, S, T Raatikainen, and J Ryhanen (2002). Composite implant of native bovine bone morphogenetic protein (BMP) and biocoral in the treatment of scaphoid nonunions - a preliminary study. Scandinavian Journal of Surgery, 91, 186-190.
24. Lind, M, S Overgaard, and Y Song (2000). Osteogenic protein 1 device stimulates bone healing to hydroxyapatitie-coated and titanium implants. Journal of Arthroplasty, 15, 339-346.
25. Meng-Hai, B, L Xing-Yan, and G Bao-Feng (1996). An implant of a composite of bovine bone morphogenetic protein and plaster of paris for treatment of femoral shaft nonunions. International Surgery, 81, 390-392.
26. Moghadam, HG, MR Urist, GK Sandor, and CM Clokie (2001). Successful mandibular reconstruction using a BMP bioimplant. Craniofacial Surgery, 12, 119-127.
27. Muschik, M, D Schlenzka, and V Ritsila (2000). Experimental anterior spine fusion using bovine bone morphogenetic protein: A study in rabbits. Journal of Orthopaedic Science, 5, 165-170.
28. Nilsson, OS, MR Urist, and EG Dawson (1986). Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. Journal of Bone and Joint Surgery, 68B, 635-642.
29. Orringer, S, WW Shaw, and LJ Borud (1999). Total mandibular and lower lip reconstruction with a prefabricated osteocutaneous free flap. Plastic and Reconstructive Surgery, 104, 793-796.
30. Reddi, AH (1998). Initiation of fracture repair by bone morphogenetic proteins. Clinical Orthopaedics and Related Research, 355 (Suppl), S66-S72.
31. Reddi, AH (2001). Bone morphogenetic proteins: From basic science to clinical applications. Journal of Bone and Joint Surgery, 83A(Suppl), S11-S16.
32. Sciadini, MF, JM Dawson, and KD Johnson (1997). Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model. Journal of Orthopaedic Trauma, 11, 496-508.
33. Simank, HG, J Manggold, and W Sebald (2001). Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model. Growth Factors, 19, 247-257.
34. Tamai, S, H Yajima, and H Ono (1993). Revascularization procedures in the treatment of Kienböck's disease. Hand Clinics, 9, 455-466.
35. Urist, MR (1965). Bone: Formation by autoinduction. Science, 150, 893-899.
36. Urist, MR, S Kovacs, and KA Yates (1986). Regeneration of an enchondroma defect under the influence of an implant of human bone morphogenetic protein. Journal of Hand Surgery, 11A, 417-419.
37. Vögelin, E, NF Jones, and JI Huang (2005). Healing of a critical-sized defect in the rat femur with a vascularized periosteal flap, a biodegradable matrix and bone morphogenetic protein. Journal of Bone and Joint Surgery, 87A, 1323-1331.
38. Vögelin, E, NF Jones, and JR Lieberman (2002). Prefabrication of bone by use of a vascularized periosteal flap and bone morphogenetic protein. Plastic and Reconstructive Surgery, 109, 190-198.
39. Wang, EA, V Rosen, and JS D'Alessandro (1990). Recombinant human bone morphogenetic protein induces bone formation. Proceedings of the National Academy of Sciences, USA, 87, 2220-2224.
40. Wozney, JM (1989). Bone morphogenetic proteins. Progress in Growth Factor Research, 1, 267-280.
41. Yasko, AW, JM Lane, and EJ Fellinger (1992). The healing of segmental bone defects, induced by recombinant human bone bone morphogenetic protein (rhBMP-2). A radiographic, histologic and biomechanical study in rats. Journal of Bone and Joint Surgery, 74A, 659-670.
42. Zegzula, HD, DC Buck, and J Brekke (1997). Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). Journal of Bone and Joint Surgery, 79A, 1778-1790.